Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing incidence of genetic and metabolic disorders
3.2.1.2 Advancements in technology
3.2.1.3 Rising awareness among healthcare professionals and parents
3.2.1.4 Rising birth rates and population growth
3.2.2 Industry pitfalls & challenges
3.2.2.1 Lack of uniformity of newborn screening procedure around the world
3.2.2.2 Stringent regulatory polices
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.2.1 Dried blood spot puncher
5.2.2 Hearing screening devices
5.2.3 Analyzers
5.2.4 Electrophoresis unit
5.2.5 Pulse oximetry
5.2.6 Other instruments
5.3 Consumables
Chapter 6 Market Estimates and Forecast, By Technology, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Tandem mass spectrometry
6.3 Oximetry
6.4 Enzyme-based assays
6.5 DNA assays
6.6 Other technologies
Chapter 7 Market Estimates and Forecast, By Test Type, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Dried blood spot
7.3 Hearing screening
7.4 Critical congenital heart defect (CCHD)
7.5 Other test types
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Diagnostic centers
8.4 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Agilent Technologies, Inc.
10.2 Bio-Rad Laboratories, Inc.
10.3 GE Healthcare
10.4 Masimo Corporation
10.5 Medtronic plc
10.6 Natus Medical Incorporated
10.7 PerkinElmer, Inc.
10.8 Thermo Fisher Scientific Inc.
10.9 Trivitron Healthcare
10.10 Waters Corporation
